← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2000Last known activity
Jul 1, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (7 distinct, 7 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Recent trials (12)
- NCT06689124Lead sponsorN/AJul 1, 2024
- NCT06689124Sponsor investigatorN/AJul 1, 2024
- NCT05076253Reponsible party - principal investigatorPhase 1/Phase 2Sep 1, 2021
- NCT05076253Overall official - principal investigatorPhase 1/Phase 2Sep 1, 2021
- NCT05076253Lead sponsorPhase 1/Phase 2Sep 1, 2021
- NCT04890704Lead sponsorEarly Phase 1Oct 1, 2018
- NCT04890704Reponsible party - principal investigatorEarly Phase 1Oct 1, 2018
- NCT04705506Reponsible party - principal investigatorN/AFeb 5, 2017
- NCT04705506Lead sponsorN/AFeb 5, 2017
- NCT02093650Overall official - principal investigatorPhase 3Mar 1, 2014
- NCT00119106CollaboratorPhase 2/Phase 3Jun 30, 2005
- NCT00148473Lead sponsorPhase 2/Phase 3Mar 1, 2000
Details
- Last known activity
- Jul 1, 2024